BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

978 related articles for article (PubMed ID: 16429394)

  • 81. Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas.
    Popnikolov NK; Ayala AG; Graves K; Gatalica Z
    Am J Clin Pathol; 2003 Aug; 120(2):161-7. PubMed ID: 12931544
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis.
    Toropainen EM; Lipponen PK; Syrjanen KJ
    Anticancer Res; 1995; 15(6B):2669-74. PubMed ID: 8669844
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
    Evans AJ; Rakha EA; Pinder SE; Green AR; Paish C; Ellis IO
    J Med Screen; 2007; 14(4):210-4. PubMed ID: 18078567
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The relationship between expression of p53/Bcl-2 and histopathological criteria in breast invasive ductal carcinomas.
    Gursan N; Karakök M; Sari I; Gursan MS
    Int J Clin Pract; 2001 Nov; 55(9):589-90. PubMed ID: 11770353
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Increased expression of osteopontin in patients with triple-negative breast cancer.
    Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
    Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract.
    Seethala RR; Barnes EL; Hunt JL
    Am J Surg Pathol; 2007 Jan; 31(1):44-57. PubMed ID: 17197918
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
    Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
    J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach.
    Flucke U; Flucke MT; Hoy L; Breuer E; Goebbels R; Rhiem K; Schmutzler R; Winzenried H; Braun M; Steiner S; Buettner R; Gevensleben H
    Histopathology; 2010 Jun; 56(7):852-9. PubMed ID: 20636789
    [TBL] [Abstract][Full Text] [Related]  

  • 89. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.
    Madjd Z; Parsons T; Watson NF; Spendlove I; Ellis I; Durrant LG
    Breast Cancer Res; 2005; 7(5):R780-7. PubMed ID: 16168124
    [TBL] [Abstract][Full Text] [Related]  

  • 90. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
    Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation.
    Richardson J; Shaaban AM; Kamal M; Alisary R; Walker C; Ellis IO; Speirs V; Green AR; Bell SM
    Breast Cancer Res Treat; 2011 Jun; 127(3):639-48. PubMed ID: 20632086
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Bcl2, p53 and clinical outcome in a series of 138 operable breast cancer patients.
    Castiglione F; Sarotto I; Fontana V; Destefanis M; Venturino A; Ferro S; Cardaropoli S; Orengo MA; Porcile G
    Anticancer Res; 1999; 19(5C):4555-63. PubMed ID: 10650810
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cell blocks allow reliable evaluation of expression of basal (CK5/6) and luminal (CK8/18) cytokeratins and smooth muscle actin (SMA) in breast carcinoma.
    Delgallo WD; Rodrigues JR; Bueno SP; Viero RM; Soares CT
    Cytopathology; 2010 Aug; 21(4):259-66. PubMed ID: 19843143
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Typical medullary breast carcinomas have a basal/myoepithelial phenotype.
    Jacquemier J; Padovani L; Rabayrol L; Lakhani SR; Penault-Llorca F; Denoux Y; Fiche M; Figueiro P; Maisongrosse V; Ledoussal V; Martinez Penuela J; Udvarhely N; El Makdissi G; Ginestier C; Geneix J; Charafe-Jauffret E; Xerri L; Eisinger F; Birnbaum D; Sobol H; ;
    J Pathol; 2005 Nov; 207(3):260-8. PubMed ID: 16167361
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases.
    Tsuda H; Takarabe T; Hasegawa F; Fukutomi T; Hirohashi S
    Am J Surg Pathol; 2000 Feb; 24(2):197-202. PubMed ID: 10680887
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
    Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM
    J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.
    Pich A; Margaria E; Chiusa L; Candelaresi G; Dal Canton O
    Br J Cancer; 1999 Feb; 79(5-6):959-64. PubMed ID: 10070897
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Oncocytic carcinoma of the breast: frequency, morphology and follow-up.
    Ragazzi M; de Biase D; Betts CM; Farnedi A; Ramadan SS; Tallini G; Reis-Filho JS; Eusebi V
    Hum Pathol; 2011 Feb; 42(2):166-75. PubMed ID: 21111455
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
    Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
    Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.
    Mylona E; Tzelepis K; Theohari I; Giannopoulou I; Papadimitriou C; Nakopoulou L
    Histopathology; 2013 Feb; 62(3):472-80. PubMed ID: 23163571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.